Current Clinical Use of Reteplase for Thrombolysis: A Pharmacokinetic-Pharmacodynamic Perspective

By Martin U.  

Clinical Pharmacokinetics, Vol. 36, Iss. 4, 1999-04 ,pp. : 265-276

Adis International

Access to resources Recommend Favorite

Pharmacokinetic/Pharmacodynamic Modelling of Antibacterials In Vitro and In Vivo Using Bacterial Growth and Kill Kinetics: The Minimum Inhibitory Concentration versus Stationary Concentration

By Johan W. Mouton  

Clinical Pharmacokinetics, Vol. 44, Iss. 2, 2005-01 ,pp. : 201-210

Adis International

Access to resources Recommend Favorite

Integration of pharmacokinetic/pharmacodynamic modeling and simulation in the development of new anti-infective agents – minimum inhibitory concentration versus time-kill curves

By Schmidt Stephan   Schuck Edgar   Kumar Vipul   Burkhardt Olaf   Derendorf Hartmut  

Expert Opinion on Drug Discovery, Vol. 2, Iss. 6, 2007-06 ,pp. : 849-860

Informa Healthcare

Access to resources Recommend Favorite

Pharmacokinetic-Pharmacodynamic Modelling of Magnesium Plasma Concentration and Blood Pressure in Preeclamptic Women

By Lu J.  

Clinical Pharmacokinetics, Vol. 41, Iss. 13, 2002-01 ,pp. : 1105-1113

Adis International

Access to resources Recommend Favorite

A Retrospective Analysis of Pharmacokinetic-Pharmacodynamic Parameters as Indicators of the Clinical Efficacy of Ceftizoxime

By Sánchez-Navarro A.   Colino C-I.   Recio M.M.S.  

Clinical Pharmacokinetics, Vol. 40, Iss. 2, 2001-01 ,pp. : 125-134

Adis International

Access to resources Recommend Favorite